IL10 and multiple sclerosis: Supporting data stems from a recent, well-executed study by Luu et al., reporting that BA, as well as the less studied SCFA pentanoate (C5), were able to effectively induce the expression of IL-10 in B cells and that pentanoate-treated B cells were able to suppress autoimmunity in a murine model of multiple sclerosis [25].